Clinical trial
The Comparative Effectiveness of Step-down Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide: A Randomized Controlled Trial (GLP1 Transition Trial)
NCT06605703 is registered in ClinicalTrials.gov with WW International Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Comparative Effectiveness of Step-down Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide: A Randomized Controlled Trial (GLP1 Transition Trial)
- Lead sponsor
- WW International Inc
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 18, 2024
- Completion date
- February 5, 2026
- Enrollment
- 226 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.